UNH testing third support touch at ~$394, with RSI near 30 on the weekly, signaling potential oversold conditions. Despite a tough Q1 with 4% EPS growth and rising medical costs, UNH boasts 10% revenue growth, a 2.08% dividend yield, and a massive 51M member base. Is this a dip to buy?
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.